Evidence map›Paper›PMID 31346256›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2020

Correction: Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Keith Nykamp, Michael Anderson, Martin Powers, John Garcia, Blanca Herrera, Yuan-Yuan Ho, Yuya Kobayashi, Nila Patil, Janita Thusberg, Marjorie Westbrook and 2 more

Abstract readPublished Erratum
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Expanding theRenal failure · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Reassessment of causality of ABCC6 missense variants associated with pseudoxanthoma elasticum based on Sherloc.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  7. Article
  8. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Keith NykampInvitae Corporation, San Francisco, CA, USA.
Michael AndersonInvitae Corporation, San Francisco, CA, USA.
Martin PowersInvitae Corporation, San Francisco, CA, USA.
John GarciaInvitae Corporation, San Francisco, CA, USA.
Blanca HerreraInvitae Corporation, San Francisco, CA, USA.
Yuan-Yuan HoInvitae Corporation, San Francisco, CA, USA.
Yuya KobayashiInvitae Corporation, San Francisco, CA, USA.
Nila PatilInvitae Corporation, San Francisco, CA, USA.
Janita ThusbergInvitae Corporation, San Francisco, CA, USA.
Marjorie WestbrookInvitae Corporation, San Francisco, CA, USA.
Invitae Clinical Genomics Group
Scott TopperInvitae Corporation, San Francisco, CA, USA. scott.topper@invitae.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31346256
PMCPMC6944637

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.